| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | $26.9B | $23.7B | $21.4B | $17.1B | $11.0B | $6.8B | $3.3B | $3.2B |
| Cost of Revenue | — | — | — | — | — | — | $0.2B | $0.2B |
| Gross Profit | — | — | — | — | — | — | $12.4B | $2.8B |
| R&D Expense | — | — | — | — | — | — | — | — |
| SG&A Expense | — | — | — | — | — | — | — | — |
| Operating Income | $8.8B | $7.6B | $5.8B | $5.1B | $2.5B | $-0.6B | $5.3B | $5.3B |
| Net Income | — | — | — | — | — | — | — | — |
| EPS (Basic) | $166.52 | $174.96 | $118.67 | $76.70 | $28.39 | $1.45 | $28.07 | $14.00 |
| EPS (Diluted) | $165.57 | $172.69 | $117.40 | $76.35 | $28.17 | $1.44 | $27.75 | $13.86 |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $29.3B | $27.7B | $24.3B | $25.4B | $23.6B | $21.9B | $21.4B | $22.7B |
| Current Assets | $22.3B | $20.5B | $17.0B | $15.8B | $13.1B | $12.2B | $9.8B | $8.4B |
| Cash & Equivalents | $17.2B | $16.2B | $12.1B | $12.2B | $11.1B | $10.6B | $6.3B | $2.6B |
| Total Liabilities | $34.8B | $31.7B | $27.1B | $22.6B | $17.5B | $17.0B | $15.5B | $13.9B |
| Current Liabilities | $16.7B | $15.6B | $13.3B | $8.5B | $6.2B | $3.4B | $5.4B | $3.6B |
| Stockholders' Equity | $-5.6B | $-4.0B | $-2.7B | $2.8B | $6.2B | $4.9B | $5.9B | $8.8B |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $9.4B | $8.3B | $7.3B | $6.6B | $2.8B | $0.1B | $4.9B | $5.3B |
| Investing Cash Flow | $-0.3B | $0.1B | $1.5B | $-0.5B | $-1.0B | $2.6B | $7.0B | $2.2B |
| Capital Expenditures | $0.3B | $0.4B | $0.3B | $0.4B | $0.3B | $0.3B | $0.4B | $0.4B |
| Financing Cash Flow | $-8.9B | $-4.2B | $-8.9B | $-4.9B | $-1.2B | $1.5B | $-8.2B | $-7.4B |